Based on the data provided, the import value of insulin in dosage forms to Indonesia is forecasted to grow steadily from 2024 to 2028. The value starts at $59.393 million in 2024 and increases to $67.508 million by 2028. For context, the import value in 2023 stood at $57.44 million.
Year-on-year percentage variations show consistent growth: - 2024: 3.4%- 2025: 3.5%- 2026: 3.3%- 2027: 3.2%- 2028: 3.0%
The Compound Annual Growth Rate (CAGR) over the last 5 years is approximately 3.28%, indicating a steady increase in insulin imports.
Future trends to watch for include potential changes in diabetes prevalence, government health policies, and advances in insulin production technology. Additionally, shifts in global trade dynamics and regional production capabilities may impact the import landscape.
